By Daria Novak The current Wuhan Coronavirus (COVID-19) pandemic has focused much-needed attention on China’s dual-use bio-research programs. “Dual-purpose bioresearch refers to bioscience research that can be used for beneficial purposes or abused for harmful ends,” wrote four Chinese scientists from Wuhan last summer, according to a Journal of Biosafety and Biosecurity. One of the researchers, Yuan Zhiming, is director of the Chinese National Biosafety Laboratory and a researcher at the Wuhan Institute of Virology (WIV). The three other researchers include another WIV researcher, Ma Haixia, a Chinese Academy of Sciences researcher Liang Huigang, and Xiang Xiaowei of the Huazhong University of Science and Technology in Wuhan. Together they explained that China lacks a law solely dedicated to biosafety regulation, or a complete supervisory system for handling new biotechnologies. These scientists are not the only ones aware of the deficits in China’s biosafety regime...
go home from us in peace. We seek not your counsel or your arms. Crouch down and lick the hand that feeds you;
may your chains set lightly upon you, and may posterity forget that ye were our countrymen!"
--Samuel Adams